'COVID-19 vaccine'指的是用于预防新型冠状病毒感染的疫苗,其类型包括mRNA疫苗、病毒载体疫苗、灭活疫苗和重组蛋白疫苗等。 COVID-19疫苗的基本介绍 COVID-19疫苗,全称为新型冠状病毒疫苗,是用于预防新型冠状病毒感染的疫苗。自2019年底新型冠状病毒(SARS-CoV-2)爆发以来,全球各国迅速...
【1】PFIZER AND BIONTECH CONCLUDE PHASE 3 STUDY OF COVID-19 VACCINE CANDIDATE, MEETING ALL PRIMARY EFFICACY ENDPOINTS 【2】Five things you need to know about:mRNA vaccine safety by Horizon Magazine, Alex Whiting, Horizon:The EU Rese...
研究成果“Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase Ⅰ clinical trial in healthy Chinese adults”于2023年发表于感染病学顶级期刊《感染杂志》(Journal of Infection)(中国科学院1区,IF:28.2),该期刊...
[2] Schrag SJ, Verani JR, Dixon BE, et al. Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of delta and omicron variant predominance in the United States....
BEIJING, June 16 (Xinhua) -- A China-developed mRNA COVID-19 vaccine as a third booster dose has been shown in human trials to be safe and able to induce an immune response against the Omicron variant. AWcorna, previously known as ARCoV, which encodes the receptor-binding domain of SARS...
近日,呼吸疾病全国重点实验室杨子峰教授团队在一区top期刊《mBio》杂志上发表了一篇题为 “A decavalent composite mRNA vaccine against both influenza and COVID-19” 的研究性论文。该研究利用阿格纳生物制药自主开发的mRNA-LNP疫苗平台,将编码季节性流感病毒、具有潜在大流行风险的禽流感病毒血凝素(HA)蛋白以及新...
A medical worker injects a dose of COVID-19 vaccine at a vaccination site of Jingcheng Hospital in Ruili City, southwest China's Yunnan Province, April 1, 2021. (Xinhua/Chen Xinbo) BEIJING, Jan. 26 (Xinhua) -- A China-developed mRNA COVID-19 vaccine has been shown to be safe, well...
Moderna COVID-19 Vaccine是一款mRNA疫苗,加强针应在完成基础免疫程序(2针免疫)后至少6个月接种。 2021年11月21日讯 /生物谷BIOON/ --莫德纳(Moderna)近日宣布,美国疾病控制和预防中心(CDC)免疫实践咨询委员会(ACIP)投票表决:推荐将COVID-19 mRNA疫苗产品Moderna COVID-19 Vaccine(mRNA-1273)加强针,以50μg剂...
It is the first mRNA vaccine to be approved for use on the Chinese mainland. The drug was approved for clinical trials in April last year. So far, it has gone through the first two trial phases, and research on its effectiveness as a booster shot has been completed. ...
非复制mRNA疫苗(non‐replicating mRNA vaccine) 自扩增mRNA(self‐amplifying mRNA,SAM)疫苗 环状RNA(circular RNA,circRNA)疫苗 COVID‐19mRNA疫苗在限制COVID‐19疫情的传播中发挥着关键作用,其他多种病毒传染病疫苗也在临床试验中取得了有前景的结果。